Morten Herholdt
Stock Analyst at HSBC
(1.05)
# 3,771
Out of 5,182 analysts
16
Total ratings
36.36%
Success rate
-8.64%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $265 → $280 | $227.79 | +22.92% | 3 | Mar 17, 2026 | |
| LH Labcorp Holdings | Upgrades: Buy | n/a | $259.57 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $116.65 | +92.88% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $183.38 | +86.50% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $129.26 | -46.62% | 2 | Apr 24, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $366.77 | +47.23% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $61.29 | -15.16% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $158.98 | +63.54% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $339.57 | -5.76% | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiates: Buy | $12 | $1.19 | +874.79% | 1 | Sep 6, 2023 |
Johnson & Johnson
Mar 17, 2026
Maintains: Buy
Price Target: $265 → $280
Current: $227.79
Upside: +22.92%
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $259.57
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $116.65
Upside: +92.88%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $183.38
Upside: +86.50%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $129.26
Upside: -46.62%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $366.77
Upside: +47.23%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $61.29
Upside: -15.16%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $158.98
Upside: +63.54%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $339.57
Upside: -5.76%
Actinium Pharmaceuticals
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.19
Upside: +874.79%